Suppr超能文献

梭形细胞黑色素瘤患者及肿瘤因素对总生存期的影响

Patient and Tumor Factors on Overall Survival in Spindle Cell Melanoma.

作者信息

Wu Xinxin, Silberstein Peter T

机构信息

College of Medicine, Creighton University School of Medicine, Omaha, USA.

Oncology, Creighton University School of Medicine, Omaha, USA.

出版信息

Cureus. 2024 Nov 22;16(11):e74247. doi: 10.7759/cureus.74247. eCollection 2024 Nov.

Abstract

INTRODUCTION

Spindle cell melanoma (SCM) is a rare melanoma subtype characterized histologically by atypical, spindled, malignant melanocytes. SCM often presents in older patients and lacks typical cytologic markers, complicating diagnosis and frequently leading to advanced disease upon presentation. While some studies have documented SCM incidence, none have thoroughly examined the demographic, socioeconomic, and treatment factors influencing survival outcomes.

OBJECTIVE

This study aims to investigate how demographic and clinical factors affect overall survival outcomes in SCM, providing updated data on demographic, socioeconomic, and tumor-related characteristics and treatment patterns.

METHODS

This retrospective cohort study analyzed histologically confirmed spindle cell melanoma and mixed spindle cell melanoma cases diagnosed between 2004 and 2021. Patient demographic, socioeconomic, and clinical factors were collected, and multivariate Cox regression analysis was performed to determine the effects on overall survival.

RESULTS

Among 9,210 SCM cases, most were White patients (97.5%), male (65.2%), and located in metropolitan areas (85.7%). Males were more likely to receive treatment at academic centers and have higher comorbidity scores. The average age at diagnosis was 67.3 years (SD±15.1). SCM in head and neck regions showed a worse prognosis compared to extremity melanomas. Surgical intervention, received by 84.9% of patients, was associated with improved overall survival. The minority of patients who received radiation and chemotherapy (13.2% and 3.3%, respectively) were linked to increased mortality risk.

CONCLUSION

Age, sex, insurance status, treatment facility type, tumor location, and stage significantly influence SCM survival outcomes. The findings suggest that SCM's prognosis is closely tied to demographic and clinical characteristics, similar to other melanoma subtypes, supporting standard treatment protocols with surgical intervention as the primary approach. This large-scale study leverages comprehensive NCDB data, contributing to the literature gap in SCM's treatment and management.

摘要

引言

梭形细胞黑色素瘤(SCM)是一种罕见的黑色素瘤亚型,组织学上表现为非典型的、梭形的恶性黑色素细胞。SCM常见于老年患者,缺乏典型的细胞学标志物,这使得诊断变得复杂,并常常导致疾病在初诊时即已进展。虽然一些研究记录了SCM的发病率,但尚无研究全面考察影响生存结局的人口统计学、社会经济和治疗因素。

目的

本研究旨在调查人口统计学和临床因素如何影响SCM的总生存结局,提供有关人口统计学、社会经济和肿瘤相关特征以及治疗模式的最新数据。

方法

这项回顾性队列研究分析了2004年至2021年间经组织学确诊的梭形细胞黑色素瘤和混合性梭形细胞黑色素瘤病例。收集了患者的人口统计学、社会经济和临床因素,并进行多因素Cox回归分析以确定对总生存的影响。

结果

在9210例SCM病例中,大多数为白人患者(97.5%)、男性(65.2%),且位于大都市地区(85.7%)。男性更有可能在学术中心接受治疗,且合并症评分更高。诊断时的平均年龄为67.3岁(标准差±15.1)。与肢体黑色素瘤相比,头颈部的SCM预后更差。84.9%的患者接受了手术干预,这与总生存改善相关。接受放疗和化疗的少数患者(分别为13.2%和3.3%)与死亡风险增加有关。

结论

年龄、性别、保险状况、治疗机构类型、肿瘤位置和分期显著影响SCM的生存结局。研究结果表明,与其他黑色素瘤亚型类似,SCM的预后与人口统计学和临床特征密切相关,支持以手术干预为主要方法的标准治疗方案。这项大规模研究利用了全面的国家癌症数据库(NCDB)数据,填补了SCM治疗和管理方面的文献空白。

相似文献

1
Patient and Tumor Factors on Overall Survival in Spindle Cell Melanoma.
Cureus. 2024 Nov 22;16(11):e74247. doi: 10.7759/cureus.74247. eCollection 2024 Nov.
2
Desmoplastic melanoma versus spindle cell melanoma: Incidence and survival, 1973 to 2017.
Medicine (Baltimore). 2018 Jul;97(29):e11563. doi: 10.1097/MD.0000000000011563.
3
Spindle cell melanoma: Incidence and survival, 1973-2017.
Oncol Lett. 2018 Oct;16(4):5091-5099. doi: 10.3892/ol.2018.9247. Epub 2018 Aug 1.
4
Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
JAMA Otolaryngol Head Neck Surg. 2017 Jan 1;143(1):34-40. doi: 10.1001/jamaoto.2016.2630.
5
Prognostic nomograms for predicting long-term overall survival in spindle cell melanoma: a population-based study.
Front Endocrinol (Lausanne). 2024 Mar 20;15:1260966. doi: 10.3389/fendo.2024.1260966. eCollection 2024.
7
Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
Am J Dermatopathol. 2008 Jun;30(3):207-15. doi: 10.1097/DAD.0b013e3181716e6b.

本文引用的文献

1
A Cohort Study: Comorbidity and Stage Affected the Prognosis of Melanoma Patients in Taiwan.
Front Oncol. 2022 Mar 3;12:846760. doi: 10.3389/fonc.2022.846760. eCollection 2022.
2
Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs.
J Womens Health (Larchmt). 2022 Jul;31(7):1012-1019. doi: 10.1089/jwh.2021.0223. Epub 2022 Jan 25.
4
The American Cancer Society's Facts & Figures: 2020 Edition.
J Adv Pract Oncol. 2020 Mar;11(2):135-136. doi: 10.6004/jadpro.2020.11.2.1. Epub 2020 Mar 1.
5
The ongoing racial disparities in melanoma: An analysis of the Surveillance, Epidemiology, and End Results database (1975-2016).
J Am Acad Dermatol. 2021 Jun;84(6):1585-1593. doi: 10.1016/j.jaad.2020.08.097. Epub 2020 Aug 27.
6
Spindle cell melanoma: Incidence and survival, 1973-2017.
Oncol Lett. 2018 Oct;16(4):5091-5099. doi: 10.3892/ol.2018.9247. Epub 2018 Aug 1.
8
The Prognostic Value of Age, Sex, and Subsite in Cutaneous Head and Neck Melanoma: A Clinical Review of Recent Literature.
Iran J Cancer Prev. 2016 Jun 8;9(3):e5079. doi: 10.17795/ijcp-5079. eCollection 2016 Jun.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验